Find trials
Search tips

A Prospective Ocular Tumor Study

Overview

About this study

The purpose of this study is to use clinical, imaging, molecular, and epidemiological investigation toward the goal of providing new knowledge about ocular tumors that will be useful in understanding, diagnosing, monitoring, and suggesting new avenues of treatment. This study does not involve experimental treatment of any ocular tumor, but rather observation of tumor natural history or outcomes following standard of care therapy, associated systemic and ocular conditions, and basic research investigations to better understand tumor biomarkers and pathophysiology.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects with an ocular tumor.
  • Subjects with a family history of an ocular tumor.
  • Subjects without an ocular tumor and no family history of ocular tumor who would serve as a control in specific case-control experiments.
  • Subjects within the United States who are not currently Mayo Clinic patients.
  • Ability to understand and willingness to sign the informed consent documents.

Exclusion Criteria:

  • Unable or unwilling to sign or understand the informed consent documents.
  • Unwilling to participate in the research.
  • Unwilling to allow genetic testing.
  • Unwilling to allow samples to be sent to other institutions for testing.
  • Not meeting the inclusion criteria.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/2/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lauren Dalvin, M.D.

Open for enrollment

Contact information:

Lauren Dalvin M.D.

(507) 284-2233

Dalvin.Lauren@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20502635

Mayo Clinic Footer